Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Good. Former Library book. All orders guaranteed and ship within 24 hours. Your purchase supports More Than Words, a nonprofit job training program for youth, empowering youth to take charge of their lives by taking charge of a business.
Choose your shipping method in Checkout. Costs may vary based on destination.
Seller's Description:
Very good. Ex-library. Trade paperback (US). Glued binding. 212 p. Contains: Illustrations, black & white. Opposing Viewpoints (Paperback). Audience: Young adult. LCCN 2008034368 Type of material Book Main title The pharmaceutical industry / Jamuna Carroll, book editor. Published/Created Detroit: Greenhaven Press, c2009. Description 212 p. : ill.; 24 cm. ISBN 9780737742381 (hardcover) 0737742380 (hardcover) 9780737742398 (pbk. ) 0737742399 (pbk. ) LC classification RM301.25. P394 2009 Related names Carroll, Jamuna. Contents Why consider opposing viewpoints? --Introduction--ch. 1. Is pharmaceutical research safe and unbiased? --Chapter preface--1. Pharmaceutical clinical trials save lives / Jan Jarboe Russell--2. Pharmaceutical clinical trials imperil lives / David Evans, Michael Smith, and Liz Willen--3. Drug industry-funded research is biased / Leonard Glantz, as told to Sara Hoffman Jurand--4. Most drug industry-funded research is not biased / Ronald Bailey--5. Requiring clinical trials registration would ensure patients' safety / Iain Chalmers, as told to the Bulletin of the World Health Organization--6. Requiring clinical trials registration would hinder drug development / International Federation of Pharmaceutical Manufacturers & Associations--Periodical bibliography--ch. 2. Are prescription drugs appropriately regulated? --Chapter preface--1. The FDA actively regulates drug safety / Henry I. Miller--2. Terminal patients should be allowed to take unapproved medications / Scott Ballenger, as told to Margot Adler--3. Terminal patients should not be allowed access to unapproved medications / Ralph W. Moss--4. The FDA should not allow pharmacists to dispense behind-the-counter drugs / Rick Kellerman--5. The FDA's black box warnings on antidepressants did not cause an increase in youth suicides / Alison Bass--Periodical bibliography--ch. 3. Are pharmaceutical marketing practices ethical? --Chapter preface--1. Drug detailing greatly influences doctors' prescribing habits / Carl Elliott--2. Drug detailing has little influence on doctors' prescribing habits / Natalie Mizik and Robert Jacobson--3. Direct-to-consumer drug marketing educates patients / Sal Perreca--4. Direct-to-consumer drug marketing harms patients / Peter R. Mansfield--5. Drug manufacturers' efforts to educate doctors are legitimate and ethical / The Pharmaceutical Research and Manufacturers of America--6. Drug manufacturers' efforts to educate doctors are unethical / Marcia Angell--Periodical bibliography--ch 4. Is the cost of prescription drugs in America appropriate? --Chapter preface--1. The cost of prescription drugs is justified / Richard A. Epstein--2. The cost of prescription drugs is outrageous / Alliance for Retired Americans Educational Fund--3. Americans should be able to buy cheaper drugs outside the country / Gil Gutknecht--4. Americans should not be permitted to buy drugs outside the country / Michelle Plasari--5. The government should allow price negotiations for Medicare drugs / National Committee to Preserve Social Security and Medicare--6. The government should not allow price negotiations for Medicare drugs / Benjamin Zycher--Periodical bibliography--For further discussion--Organizations to contact--Bibliography of books--Index. Subjects Drug development--Popular works. Drugs--Research--Popular works. Pharmaceutical industry--Popular works. Notes Includes bibliographical references (p. 195-199) and index. Series Opposing viewpoints series Opposing viewpoints series (Unnumbered) Dewey class no. 615/.19
